Resmed Inc. buy Royal Bank of Canada
Start price
31.10.25
/
50%
€212.60
Target price
31.10.26
€261.85
Performance (%)
1.46%
Price
15:46
€215.70
Summary
This prediction is currently active. With a performance of 1.46%, the BUY prediction by Royal_Bank_of_Canada for Resmed Inc. is trending in the right direction. This prediction currently runs until 31.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -1.518% | -1.518% |
| iShares Core DAX® | 1.330% | -1.723% |
| iShares Nasdaq 100 | 1.099% | -2.569% |
| iShares Nikkei 225® | 1.265% | -6.613% |
| iShares S&P 500 | 1.000% | -0.871% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Royal Bank Of Canada from $300.00 to $303.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat